GSK3B and neoplasm: Further studies have shown that UFM1 can inhibit the phosphorylation of AKT and downstream GSK3β by binding to PDK1 and increasing its ubiquitination, thereby inhibiting EMT of gastric cancer cells and exerting a tumor suppressor function.